Search results for "Bile"

showing 10 items of 2148 documents

Case report: Trans-papillary free stenting of the cystic duct and of the common bile duct in a double biliary ducts anastomoses of a right lobe livin…

2021

Abstract Background One of the major issues related to the living donor liver transplantation recipient outcome is still the high rate of biliary complication, especially when multiple biliary ducts are present and multiple anastomoses have to be performed. Case presentation and conclusion We report a case of adult-to-adult right lobe living donor liver transplantation performed for a recipient affected by alcohol-related cirrhosis with MELD score of 17. End-stage liver disease was complicated by refractory ascites, portal hypertension, small esophageal varices and portal gastropathy, hypersplenism, and abundant right pleural effusion. Here in the attached video we described the adult-to-ad…

Malemedicine.medical_specialtyCirrhosismedicine.medical_treatmentBiliary anastomoseslcsh:SurgeryAnastomosisLiver transplantationEsophageal varicesCholestasisLiver Cirrhosis AlcoholicmedicineLiving DonorsHumansCommon Bile DuctCommon bile ductbusiness.industryLiving donor liver transplantationAnastomosis SurgicalCystic Ductlcsh:RD1-811General MedicineMiddle Agedmedicine.diseaseSurgeryLiver TransplantationTransplantationmedicine.anatomical_structureTreatment OutcomeCystic ductSurgeryStentsBile DuctsbusinessResearch ArticleBMC surgery
researchProduct

Pharmacokinetics and bioavailability of diclofenac in the rat.

1991

Diclofenac sodium is a widely used drug with interesting absorption and disposition features when administered to laboratory animals. The present study was undertaken to assess the pharmacokinetics of the drug after iv and gastrointestinal dosing to rats. Renal excretion of unchanged drug was negligible, but biliary excretion of the drug (unchanged and conjugated) was detected in bile duct-cannulated rats; it accounted for 27.2 and 31.2% of the total dose following iv and intraduodenal administration, respectively. Most of the drug excreted in the bile was conjugated diclofenac; unchanged drug accounted for only 4.7 and 5.4% of total diclofenac excreted in the bile after iv and intraduodena…

Malemedicine.medical_specialtyDiclofenacDuodenumAdministration OralBiological AvailabilityPharmacologyIntestinal absorptionInjectionsDiclofenacPharmacokineticsOral administrationInternal medicinemedicineAnimalsBilePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsEnterohepatic circulationChemistryRats Inbred StrainsDiclofenac SodiumBioavailabilityRatsstomatognathic diseasesmedicine.anatomical_structureEndocrinologyIntestinal AbsorptionData Interpretation StatisticalInjections IntravenousDuodenummedicine.drugJournal of pharmacokinetics and biopharmaceutics
researchProduct

Endoscopic stenting for postoperative biliary strictures due to hepatic hydatid disease: effectiveness and long-term outcome.

2003

Background Postoperative strictures due to hepatic hydatid disease caused by Echinococcus surgery is considered to be a rare cause of benign bile duct strictures, especially in the Western world. Goals The aim of this retrospective study is to demonstrate possible characteristics of the strictures as well as the effectiveness of long-term endoscopic stenting. Study Between 1994 and 2001, we treated 10 of these cases in our clinic. All patients had surgery for hepatic Echinococcus disease one or more times. These types of benign biliary strictures, secondary to surgery of hepatic hydatid disease, were multiple and located in the proximal common bile duct. Endoscopic stent therapy was carried…

Malemedicine.medical_specialtyEchinococcosis Hepaticmedicine.medical_treatmentCommon Bile Duct DiseasesConstriction PathologicMedicineAnimalsHumansEndoscopic stentingEndoscopy Digestive SystemAgedRetrospective StudiesbiologyCommon bile ductbusiness.industryGastroenterologyStentRetrospective cohort studyMiddle Agedmedicine.diseasebiology.organism_classificationSurgeryStenosisEchinococcusmedicine.anatomical_structureBiliary tractFemaleStentsComplicationbusinessJournal of clinical gastroenterology
researchProduct

Direct transnasal cholangioscopy with ultraslim endoscopes: a one-step intraductal balloon-guided approach.

2011

Background Direct cholangioscopy using an ultraslim endoscope is an attractive alternative to the conventional mother–baby endoscope system because it provides a single-operator platform and high-resolution image quality and allows advanced therapeutic interventions. However, biliary access is cumbersome and usually requires previous guidewire placement via retrograde cholangiography. Objective To evaluate the feasibility of a 1-step transnasal cholangioscopy (TNC) technique using an ultraslim endoscope with an intraductal balloon to maintain access without previous guidewire placement. Design Prospective, observational clinical feasibility study. Setting Single tertiary referral center. Ma…

Malemedicine.medical_specialtyEndoscopemedicine.medical_treatmentBiopsyForcepsArgon plasma coagulationBile Duct DiseasesCatheterizationBiliary diseaseCholangiographyMedicineHumansRadiology Nuclear Medicine and imagingEndoscopy Digestive SystemProspective StudiesAgedAged 80 and overmedicine.diagnostic_testCommon bile ductbusiness.industryGastroenterologyStentMiddle Agedmedicine.diseaseEndoscopySurgerymedicine.anatomical_structureFeasibility StudiesFemaleRadiologybusinessGastrointestinal endoscopy
researchProduct

Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38…

2019

IF 3.287 (2017); International audience; IntroductionCombination of cisplatine and Gemcitabine (CisGem) is the reference 1st line Chemotherapy in patients with advanced biliary cancer. FOLFIRINOX demonstrated an overall survival superiority when compared to gemcitabine in 1st line for patients with metastatic pancreatic adenocarcinoma. Because of similarities between pancreatic and biliary cancers, we proposed a randomized trial comparing mFOLFIRINOX and CisGEm.AimPRODIGE38-AMEBICA is a phase II/III trial evaluating efficacy of modifed FOLFIRINOX (D1 bolus removed) or CisGEm on patients with locally advanced non resectable or metastatic biliary tract cancer.Patients and methodsMain inclusio…

Malemedicine.medical_specialtyFOLFIRINOXmedicine.medical_treatmentModified folfirinoxLeucovorinAntineoplastic Agents[SDV.CAN]Life Sciences [q-bio]/CancerAdvanced biliary cancerIrinotecanDeoxycytidineGastroenterology03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsCarcinomaHumansMedicineNeoplasm InvasivenessNeoplasm StagingChemotherapyHepatologybusiness.industryGallbladderCarcinomaGastroenterologyMetastatic Pancreatic Adenocarcinomamedicine.diseaseGemcitabinePrimary tumorGemcitabine3. Good healthOxaliplatinmedicine.anatomical_structureBile Duct NeoplasmsBiliary tract030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologyFluorouracilFranceCisplatinDrug Monitoringbusinessmedicine.drug
researchProduct

Risk of gallstone disease in advanced chronic phase of fascioliasis: an experimental study in a rat model.

2003

In Wistar rats experimentally infected with Fasciola hepatica, the association between time of infection, number of flukes, rat weight, and serum lipid levels and the risk of developing pigment stones in the main bile duct was examined using data obtained at 100, 200, 300, 400, and 500 days postinfection. Gallstone presence increased with infection time. The relative risk of gallstone disease increased when the number of flukes per rat and rat weight increased. The presence of gallstones was associated with serum high-density lipoproteins and triglyceride levels. In a multivariate analysis, the association between gallstones and rat weight disappeared after adjustment for serum lipids. The …

Malemedicine.medical_specialtyFascioliasisBlood lipidsPhysiologyGastroenterologyCholelithiasisRisk FactorsInternal medicineparasitic diseasesmedicinePrevalenceImmunology and AllergyFasciola hepaticaAnimalsHumansRats WistarCommon bile ductbiologyBile ductGallstonesLiver flukeFasciola hepaticamedicine.diseasebiology.organism_classificationRatsDisease Models AnimalInfectious Diseasesmedicine.anatomical_structureBiliary tractChronic DiseaseLipoproteinThe Journal of infectious diseases
researchProduct

Functional, Biochemical, and Morphological Hepatobiliary Effects in Rats Chronically Exposed to a Steroidal Antiandrogen

1996

Abstract Yellow–brown deposits in intrahepatic bile ducts and portal macrophages were observed for male, but not female, Sprague–Dawley rats fed zanoterone, a steroidal antiandrogen, for ≥3 months. The lesion did not affect biliary canaliculi and was associated with changes of biliary epithelium, portal chronic inflammation, and bile duct proliferation. Deposit formation was assumed to be related to a gender-related anomaly in bile composition and/or flow. Therefore, the pathogenesis of the lesion was investigated in male, female, and orchiectomized rats. Hepatobiliary structure and function were evaluated after 3 months of treatment and 3 months of reversibility. Drug biliary disposition w…

Malemedicine.medical_specialtyIntrahepatic bile ductsCholestasis IntrahepaticBiologyToxicologySulfobromophthaleinBile Acids and SaltsRats Sprague-DawleyLesionEatingchemistry.chemical_compoundLiver Function TestsCholestasisInternal medicinemedicineAnimalsBileBiliary TractZanoteronePharmacologySex CharacteristicsBody WeightHepatobiliary diseaseAndrogen AntagonistsBile PigmentsPregnanesmedicine.diseaseBile duct proliferationRatsCholesterolEndocrinologyLiverchemistryBiliary tractPyrazolesFemalemedicine.symptomOrchiectomyToxicology and Applied Pharmacology
researchProduct

Bioavailability of nevirapine in rats after oral and subcutaneous administration, in vivo absorption from gastrointestinal segments and effect of bil…

2011

Abstract Nevirapine is a non-nucleoside reverse transcriptase inhibitor of human immunodeficiency virus type-1. The usual dosing regimen is 200 mg twice/day. Reducing the dosing frequency would significantly improve treatment adherence and quality of life of patients. To study new forms of administration, it is necessary to do pre-clinical studies and know the absorption characteristics of nevirapine in laboratory animals. However, there are no studies about its bioavailability in rats and hardly any about its pharmacokinetic. The objectives of this study were to describe the pharmacokinetics of nevirapine in rats after intravenous, oral and subcutaneous administration, to assess its absorp…

Malemedicine.medical_specialtyNevirapineDuodenumInjections SubcutaneousPharmaceutical ScienceAdministration OralBiological AvailabilityIleumAbsorption (skin)PharmacologyGastroenterologyIntestinal absorptionPharmacokineticsSpecies SpecificityOral administrationInternal medicinemedicineAnimalsBileHumansNevirapineRats Wistarbusiness.industrydigestive oral and skin physiologyBioavailabilityRatsGastrointestinal Tractmedicine.anatomical_structureIntestinal AbsorptionInjections IntravenousDuodenumReverse Transcriptase Inhibitorsbusinessmedicine.drugInternational journal of pharmaceutics
researchProduct

Permanent stenting in “unextractable” common bile duct stones in high risk patients. A prospective randomized study comparing two different stents

2007

BACKGROUND: Endoscopic sphincterotomy (ES) and stone extraction is the treatment of choice for bile duct stones. Therefore, if ES and conventional stone extraction fail, further treatment is mandatory. Insertion of a biliary endoprosthesis is an effective option. MATERIALS AND METHODS: We treated 30 high-risk patients (17 women and 13 men, mean age 82 years) affected by difficult common bile duct stones. The patients were randomly assigned preoperatively using closed envelopes (blind randomization) into two groups to receive insertion of polyethylene or hydrophilic hydromer-coated polyurethane stent, respectively. Follow-up was achieved by contacting referring physicians and patient's relat…

Malemedicine.medical_specialtyPalliative caremedicine.medical_treatmentPolyurethanesComorbidityGallstonesSphincterotomy EndoscopicPostoperative ComplicationsCoated Materials BiocompatibleLiver Function TestsCholestasisRisk FactorsCause of DeathmedicineHumansAgedAged 80 and overCholangiopancreatography Endoscopic RetrogradePermanent stenting difficult stones prospective study stentsCommon bile ductBile ductbusiness.industryPalliative CarePovidoneStentEquipment DesignCholestasis ExtrahepaticVascular surgerymedicine.diseaseSettore MED/18 - Chirurgia Generalemedicine.anatomical_structurePolyethyleneCardiothoracic surgeryEquipment FailureFemaleStentsSurgeryRadiologybusinessFollow-Up StudiesIsocyanatesAbdominal surgeryLangenbeck's Archives of Surgery
researchProduct

Value of magnetic-resonance cholangio-pancreatography (MRCP) after unsuccessful endoscopic-retrograde cholangio-pancreatography (ERCP).

1997

Background and Study Aims: The present study tries to evaluate the success rate of MRCP when two attempts by experts to perform ERCP in a center failed. Patients and Methods: From March 1996 to December 1996 thirteen patients fulfilled the inclusion criteria. The MR cholangiopancreatograms were acquired using commercially available software in a clinical MR scanner (Magnetom Expert 1T-Scanner, Siemens, Erlangen, Germany). MRCP utilized heavily T2-weighted turbo-spin echo sequences with fat supression (HASTE). Maximum intensity projection (MIP) of the pancreatic duct and biliary tree was then carried out. Additionally, T1-weighted sequences were obtained using the breath-hold technique. Resu…

Malemedicine.medical_specialtyPercutaneousPancreatic pseudocystBiliary Tract DiseasesmedicineImage Processing Computer-AssistedHumansMedical diagnosisAgedPancreatic ductAged 80 and overCholangiopancreatography Endoscopic Retrogrademedicine.diagnostic_testbusiness.industryBile ductGastroenterologyPancreatic DiseasesMagnetic resonance imagingMiddle Agedmedicine.diseaseMagnetic Resonance Imagingmedicine.anatomical_structureMaximum intensity projectionFemaleRadiologybusinessEndoscopic retrograde cholangio-pancreatographyEndoscopy
researchProduct